Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Breast Neoplasm Female × Propofol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Colonic Neoplasms 4 Breast Neoplasms 4 Brain Neoplasms 4 Respiratory Aspiration 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Postoperative Complications 2 Pituitary Neoplasms 2 Lung Neoplasms 2 Hypoxia 2 Emergence Delirium 2 Uterine Neoplasms 1 Thyroid Nodule 1 Sedation 1 Respiration Disorders 1 Rectal Neoplasms 1 Rare Diseases 1 Prostatic Neoplasms 1 Postoperative Cognitive Complications 1 Pancreatic Neoplasms 1 Neoplastic Cells, Circulating 1 Myofibroma 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Neoplasms 1 Leukemia 1 Glioma 1 Endoplasmic Reticulum Stress 1

Interventions

pyrotinib 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Ondansetron 1 Morphine 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03117894 2021-06-04

PECS-2 for Breast Surgery

Umeå University

Phase NA Completed

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡